cancer therapeutics (BerGenBio)

N/A

Report date: 2025/03/13 14:24:18

Base Information

Drug Namecancer therapeutics (BerGenBio)
Drug Alias NameBGB-101BGB-109BGB-003BGB-001
ClassificationBiologics
Mechanisms of ActionAXL receptor tyrosine kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBergenbio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBergenbio
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A